Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-25-004477
Filing Date
2025-02-07
Accepted
2025-02-07 17:57:13
Documents
1
Period of Report
2025-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1738969027.html 3  
1 FORM 3 wk-form3_1738969027.xml 3 2139
  Complete submission text file 0001628280-25-004477.txt   3863
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2525 DUPONT DR IRVINE CA 92612
Business Address
INGRAM DOUGLAS S (Reporting) CIK: 0001190644 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38042 | Film No.: 25603091